PCN73 Cost Effectiveness of Zoledronic Acid vs. Pamidronate or No therapy for the Treatment of Bone Metastases Secondary to Prostate Cancer
Abstract
Authors
J.A. Carter M. Bains D. Chandiwana S. Kaura M.F. Botteman
J.A. Carter M. Bains D. Chandiwana S. Kaura M.F. Botteman
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now